Literature DB >> 19406659

Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT.

C A Robertson1, D Hawkins Evans, H Abrahamse.   

Abstract

Photodynamic therapy (PDT) has been used for many years, but it is only now becoming widely accepted and utilized. Originally it was developed as a tumor therapy and some of its most successful applications are for non-malignant diseases. This article provides a broad review of different parameters used and mechanisms instituted in PDT such as photosensitizers (PS), photochemistry and photophysics, cellular localization, cellular signaling, cell metabolism and modes of cell death that operate on a cellular level, as well as photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. These specific cellular mechanisms are most commonly applied in PDT and for the most part are often researched and exploited. If the combination of these specific parameters and mechanisms can be optimized within PDT it could possibly be used as a suitable alternative for the treatment and management of specific cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406659     DOI: 10.1016/j.jphotobiol.2009.04.001

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  141 in total

1.  Lipid composition affects the rate of photosensitized dissipation of cross-membrane diffusion potential on liposomes.

Authors:  Shany Ytzhak; Joseph P Wuskell; Leslie M Loew; Benjamin Ehrenberg
Journal:  J Phys Chem B       Date:  2010-08-12       Impact factor: 2.991

2.  Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.

Authors:  Alyssa M Master; Megan Livingston; Nancy L Oleinick; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2012-07-19       Impact factor: 4.939

3.  Imbalance of Ca2+ and K+ fluxes in C6 glioma cells after PDT measured with scanning ion-selective electrode technique.

Authors:  Sheng-Li Hu; Peng Du; Rong Hu; Fei Li; Hua Feng
Journal:  Lasers Med Sci       Date:  2014-01-24       Impact factor: 3.161

4.  Development of a multifunctional luciferase reporters system for assessing endoplasmic reticulum-targeting photosensitive compounds.

Authors:  Shengchao Lin; Lingling Zhang; Kecheng Lei; Anle Zhang; Ping Liu; Jianwen Liu
Journal:  Cell Stress Chaperones       Date:  2014-07-02       Impact factor: 3.667

Review 5.  Recent advances in liposome formulations for breast cancer therapeutics.

Authors:  Biyao Yang; Bo-Ping Song; Shaina Shankar; Anna Guller; Wei Deng
Journal:  Cell Mol Life Sci       Date:  2021-05-11       Impact factor: 9.261

6.  Photo-modulation of zinc phthalocyanine-treated breast cancer cell line ZR-75-1 inhibited the normal tumor activity in vitro.

Authors:  Arezoo Rezaie Nezhad Zamani; Mohammad Reza Mashayekhi; Mahdieh Farhoudi Sefidan Jadid; Yousef Faridvand; Habib Tajalli; Reza Rahbarghazi
Journal:  Lasers Med Sci       Date:  2018-08-24       Impact factor: 3.161

7.  A Photosensitizer-Loaded DNA Origami Nanosystem for Photodynamic Therapy.

Authors:  Xiaoxi Zhuang; Xiaowei Ma; Xiangdong Xue; Qiao Jiang; Linlin Song; Luru Dai; Chunqiu Zhang; Shubin Jin; Keni Yang; Baoquan Ding; Paul C Wang; Xing-Jie Liang
Journal:  ACS Nano       Date:  2016-03-10       Impact factor: 15.881

8.  Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.

Authors:  María García-Díaz; Masayoshi Kawakubo; Pawel Mroz; M Lluïsa Sagristà; Margarita Mora; Santi Nonell; Michael R Hamblin
Journal:  J Control Release       Date:  2012-07-27       Impact factor: 9.776

Review 9.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

10.  In vivo wireless photonic photodynamic therapy.

Authors:  Akshaya Bansal; Fengyuan Yang; Tian Xi; Yong Zhang; John S Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.